Curriculum Vitae

PROF. DR. SHANGGAR A/L KUPPUSAMY

Professor
  • Department of Surgery
    Faculty of Medicine
  • drshanggar
  • 79492441

AREAS OF EXPERTISE

  • UROLOGY
    Board of Urology Malaysia
  • UROLOGY

ACADEMIC QUALIFICATION

  • Doctoral Degree (PhD)
    University of The West of England, Bristol
  • FRCS (Urol)(Glasg.), (Urology)
    Royal College of Physicians & Surgeons of Glasgow
  • MS, (Surgery)
    Universiti Malaya (UM)
  • MBBS, (PERUBATAN)
    Kasturba Medical College, India

ADMINISTRATIVE DUTIES

  • Head of Department
    01 Jan 2024 - present (Department of Surgery, Faculty of Medicine)
  • Coordinator- Phase II MBBS
    01 Nov 2008 - present (Department of Surgery, Faculty of Medicine)
  • BOARD MEMBER
    01 Nov 2020 - present (National)
  • Honorary Secretary
    27 Dec 2020 - present (National)
  • Head of Department
    16 Nov 2022 - 31 Dec 2023 (Department of Surgery, Faculty of Medicine)
  • Committee Member
    01 Sep 2021 - 31 Aug 2023 (University Malaya)
  • Member
    01 Aug 2021 - 31 Jul 2023 (Department of Surgery, Faculty of Medicine)
  • Head of Unit
    02 Nov 2020 - 01 Nov 2022 (Department of Surgery, Faculty of Medicine)
  • Coordinator
    01 Jul 2020 - 01 Jul 2022 (Department of Surgery, Faculty of Medicine)
  • Coordinator
    01 Jul 2020 - 30 Jun 2022 (Department of Surgery, Faculty of Medicine)
  • Coordinator
    01 Jul 2020 - 30 Jun 2022 (Faculty)
  • Committee Member _Department Level
    01 Jan 2021 - 31 Dec 2021 (Department of Surgery, Faculty of Medicine)
  • Honorary Secretary Malaysia Urological Foundation (MUF)
    01 Jul 2018 - 31 Dec 2020 (National)
  • Committee member of Malaysian Urological Association
    16 Dec 2018 - 15 Dec 2020 (National)
  • Examiner - Malaysian Urological Association
    03 Nov 2019 - 03 Nov 2019 (National)
  • Chairperson - 17th Urological Association of Asia Congress 2019
    07 Aug 2019 - 10 Aug 2019 (International)
  • Facilitator- A Teacher's Toolkit Workshop
    19 Jun 2019 - 19 Jun 2019 (University Malaya)
  • Facilitator-1st Onco Summit 2019
    12 Jan 2019 - 12 Jan 2019 (National)
  • Chairman
    28 Sep 2015 - 31 Dec 2018 (Department of Surgery, Faculty of Medicine)
  • Committee member- Research Committee
    02 Mar 2015 - 31 Dec 2018 (Department of Surgery, Faculty of Medicine)
  • Head Coordinator
    06 Jan 2016 - 31 Dec 2016 (Department of Surgery, Faculty of Medicine)
  • Head Coordinator
    01 Oct 2015 - 31 Dec 2016 (Department of Surgery, Faculty of Medicine)

MEMBERSHIPS

  • LIFE MEMBER, MEMBER
    Since 2018 (National)
  • GENERAL MEDICAL COUNCIL, MEMBER
    Since 2010 (International)
  • MALAYSIAN MEDICAL ASSOCIATION, LIFE MEMBER
    Since 2009 (National)
  • ELECTED HONORARY SECRETARY, SECRETARY
    Since 2018 (National)
  • NATIONAL TRANSPLANT ADVISORY COUNCIL, COMMITTEE MEMBER
    2021 to 2023 (National)
  • MEMBER, MEMBER
    2022 to 2022 (International)
  • SUBSPECIALTY EDUCATION SUBCOMMITTEES, MEMBER
    2020 to 2022 (National)
  • ADVISOR TO ORGANISING COMMITTEE-ENDOUROLOGY IN THE COVID ERA, ADVISORY BOARD
    2021 to 2021 (International)
  • UNIVERSITY MALAYA ACADEMIC CLUB (UMAC), MEMBER
    2021 to 2021 (University)
  • UROLOGICAL ASSOCIATION OF ASIA, ACTIVE MEMBER
    2017 to 2020 (International)
  • EUROPEAN ASSOCIATION OF UROLOGY, MEMBER
    2018 to 2019 (International)

AWARD AND STEWARDSHIP

  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2021 (University)
  • Appreciation as local organizing committee for MUC 2020
    Malaysian Urology Association, 2020 (National)
  • Best Video Presentation
    Urological Association of Asia, 2019 (International)
  • Best Poster Award
    University of Malaya, 2018 (University)
  • UAA-Youth Section Fellowship
    Urological Association of Asia, 2018 (International)
  • Best Video Presentation
    Malaysian Urological Association, 2018 (National)
  • Best Lecturer for Surgery Session 2015/2016
    University of Malaya, 2017 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2017 (University)
  • Invited consultant for mass media- Prostate cancer awareness
    Astro, 2016 (Community)
  • Invited consultant for mass media- Prostate cancer treatment
    Astro, 2016 (Community)
  • Invited Consultant for Mass media
    Astro, 2016 (Community)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2016 (University)
  • Kecemerlangan Perkhidmatan 2015
    Universiti Malaya, 2015 (University)
  • Most number of participants in a cancer survivor relay run
    Malaysia Book of Records, 2015 (National)
  • Best Oral Award
    Malaysian Urological Association, 2010 (National)
  • Best Poster Award at World Video Urology Conference 2009
    Malaysian Urological Association, 2009 (International)
  • Sanofi-Aventis Prostate Cancer Research Award
    Malaysian Urological Association, 2007 (National)

PUBLICATIONS

Article in Journal
WoS
  1. Chan, Chee Ken; Lam, Thian Yin; Seevalingam, Kanesh Kumaran; Rajandram, Retnagowri; Kuppusamy, Shanggar (2022). The Impact of Recurrent Waves of COVID-19 on the Mental Health of Medical Students: A Cross-Sectional Study, ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH. . doi:10.1177/10105395221077061
  2. Kanmalar, M.; Sani, Siti Fairus Abdul; Kamri, Nur Izzahtul Nabilla B.; Said, Nur Akmarina B. M.; Jamil, Amirah Hajirah B. A.; Kuppusamy, S.; Mun, K. S.; Bradley, D. A. (2022). Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review, CELLULAR & MOLECULAR BIOLOGY LETTERS. 27(1). doi:10.1186/s11658-022-00307-x
  3. Rajandram, Retnagowri; Koong, Jun K.; Quek, Kia F.; Lee, Eng G.; Razack, Azad H. A.; Kuppusamy, Shanggar (2022). Ethnic differences in serum testosterone concentration among Malay, Chinese and Indian men: A cross-sectional study, CLINICAL ENDOCRINOLOGY. . doi:10.1111/cen.14682
  4. San Loh, Pui; Chaw, Sook Hui; Foong, Yi Xian; Ramasamy, Dhurgka; Zaki, Rafdzah Ahmad; Kuppusamy, Shanggar; Ong, Teng Aik; See, Mee Hoong; Khor, Hui Min (2022). Psychological distress among elderly surgical patients who had their surgery postponed during the COVID-19 pandemic, PERIOPERATIVE MEDICINE. 11(1). doi:10.1186/s13741-022-00242-7
  5. Tamalvanan, Vethunan; Rajandram, Retnagowri; Kuppusamy, Shanggar (2022). Reduction of pre-procedural anxiety for repeat sessions in extracorporeal shockwave lithotripsy (ESWL) reduces pain intensity: A prospective observational study, MEDICINE. 101(37). doi:10.1097/MD.0000000000030425
  6. Chai, C. A., Yeoh, W. S., Rajandram, R., Aung, K. P., Ong, T. A., Kuppusamy, S., . . . Teoh, J. Y. (2021). Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. Frontiers in Surgery, 8, 6. doi: 10.3389/fsurg.2021.659292
  7. Schutz, F. A. B., Sirachainan, E., Kuppusamy, S., Hoa, N. T. T., Dejthevaporn, T., Bahadzor, B., . . . Garg, A. (2021). Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel. Therapeutic Advances in Medical Oncology, 13, 13. doi: 10.1177/1758835920985464
  8. Perumal, K., Mun, K. S., Yap, N. Y., Razack, A. H. A., Gobe, G. C., Ong, T. A., . . . Rajandram, R. (2020). A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma. BioMed Research International, 2020, 10. doi: 10.1155/2020/3682086
  9. Phyo, A. K., Mun, K. S., Kwan, K. C., Ann, C. C., & Kuppusamy, S. (2020). Genitourinary extramammary Paget's disease: review and outcome in a multidisciplinary setting. International Journal of Clinical and Experimental Pathology, 13(9), 2369-2376.
  10. Yii, R. S. L., Lim, J., Sothilingam, S., Yeoh, W. S., Fadzli, A. N., Ong, T. A., . . . Razack, A. H. A. (2020). Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia. Asian Journal of Surgery, 43(1), 87-94. doi: 10.1016/j.asjsur.2019.02.014
  11. Tan, J. S. J., Ong, K. C., Ong, D. B. L., Wu, Y. S., Razack, A., Kuppusamy, S., . . . Rhodes, A. (2019). Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer. Malaysian Journal of Pathology, 41(3), 243-251.
  12. Kuppusamy, S., Faizal, N., Quek, K. F., Razack, A. H., Dublin, N. (2010). The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound biopsy of prostate: a prospective randomised control study, World Journal of Urology. 28(6), 673-676
Others
  1. Amat, N., Philip, E.F., Chai, C.A., Yeoh, W.S., Lim, J., Fadzli, A.N., Kuppusamy, S. & Ong, T.A. (2021). The impact of population lockdown on the referral pattern for urology in a COVID-19 designated tertiary hospital in Malaysia. Urological Science, 32(1), 23-26.
  2. Chai CA, Yeoh WS, Rajandram R, Aung KP, Ong TA, Kuppusamy S, Nazran A, Kumaran K, Razack AHA, Teoh JY (2021). Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. Frontiers of Surgery 8: 659292. doi: 10.3389/fsurg.2021.659292.
  3. Aung KP, Mun KS, Kong CK, Chai CA, Shanggar K. (2020). Genitourinary extramammary Paget's disease: review and outcome in a multidisciplinary setting. Int J Clin Exp Pathol, 13 (9): 2369 - 2376
  4. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer
  5. Yii RSL et al., Predictive factors of prostate cancer diagnosis with PSA 4.0e10.0 ng/ml in a multi-ethnic Asian population, Malaysia, Asian Journal of Surgery, https://doi.org/10.1016/j.asjsur.2019.02.014
  6. Kuppusamy S, Quek KF, Rajandram R, Razack AHA and Dublin N (2018). Revisiting prostate specific antigen density (PSAD): a prospective analysis in predicting the histology of prostate biopsy. International Journal of Clinical and Experimental Medicine (Accepted)
  7. Dublin N and Kuppusamy S. Dilatation/urethotomy/meatomy - indications and outcomes
  8. Prevathe Poniah, Shamsul Mohd Zain, Azad Hassan Abdul Razack, Shanggar Kuppusamy, Shankar Karuppayah, Hooi Sian Eng, Zahurin Mohamed: Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urologic Oncology 05/2017;, DOI:10.1016/j.urolonc.2017.04.017
  9. Poniah P, Mohamed Z, Apalasamy YD, Zain SM, Kuppusamy S, Razack AHA. Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. Int J Clin Exp Med. 2015; 8(10): 19232-40.
  10. Ibrahim, Fatimah; Sian, Tee Chee; Shanggar, Kuppusamy; Razack, Azad Hassan. 2013. Muslim Prayer movement as an alternative therapy in the treatment of erectile dysfunction: A preliminary study. J. Phys. Ther. Sci. 25: 1087-1091.
  11. Kuppusamy S, Gillatt D.Managing patients with acute urinary retention.Practitioner 2011; 255(1739):21-23.
  12. K Shanggar, MZ Zulkifli, AH Razack, N Dublin. Granulomatous Prostatitis: A Reminder to Clinicians. Med J Malaysia Vol 65, No 1, March 2010, 21-22.
  13. Shanggar K, Ng CH, Razack AH, Dublin N. Squamous Cell Carcinoma of Scrotum: a rare case of scrotal neoplasm.2010 Journal of the University of Malaya Medical Centre; Vol 13, Number 1, 59-62.
  14. Shanggar Kuppusamy, Faizal N, Quek, KF; Razack, AH; Dublin, N.2010 The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound (TRUS) biopsy of prostate: a prospective randomized study. World J Urol. Published Online 11th July 2010.
  15. Koh PS, Shanggar K, Razack AH, Lee G.2008.Congenital Bilateral Aplasia of Vas Deferens (CBAVD): A Reminder to Clinicians. Journal of the University of Malaya Medical Centre Vol 11(2):89-90.
  16. Shanggar K, Muhilan P, Dublin N, Eng Geap George Lee, Razack AH. An Unusual Presentation of a Rare Rhabdomyosarcoma of Urinary Bladder and Prostate. Journal of the University of Malaya Medical Centre; Vol 10, Number 2, 2007, 57-59.
Article in Proceeding
  1. AN Fadzli, N Amat, S Kuppusamy. (2023). Pushing the limits of an old friend: flexible vesicolithotripsy under local anaesthesia. 132(S2), 29
  2. Amat Norshuhada, Lim Jeffery, Fadzli Ahmad Nazran, Kuppusamy Shanggar, Teng Aik Ong. (2023). Ventriculoperitoneal shunt migrated into urinary bladder: A case report and literature review. 132(S2), 4
  3. Ling DCW, Yeoh WS, Fadzli AN, Kuppusamy S, ong TA. (2023). Rare reported case of PCNL in a transplanted kidney. 132(S2), 35.
  4. Muhammad Fairuz Shah Abd. Karim, Ahmad Nazran Fadzli, Shanggar Kuppusamy (2023). Systematic approaches in organising mass circumcision programs for children in public. 132(S2),37.
  5. Qing Yong Teng, Marniza Saad, Adlinda Alip, Wei Sien Yeoh, Shanggar Kuppusamy, Teng Aik Ong. (2023). Real-world utilisation of prostate-specific membrane antigen (PSMA) PET-CT in patients with prostate cancer at a tertiary referral centre in Kuala Lumpur. 132(S2), 29
  6. Sugania Malar Chinapayan, Shanggar Kuppusamy, Ning Yi Yap, Glenda Gobe, Retnagowri Rajandram, (2023). Inhibition of Visfatin suppresses renal cell carcinoma proliferation in cellular models. 132(S2), 14.
  7. Vishal Singh Dhillon, Ahmad Nazran Bin Fadzli, Shanggar Kuppusamy, Kanesh Kumaran Seevalingam, Ahmad Rafizi Hariz Ramli, Sharul Amry Bin Hashim, Kamarajan Ramayah, Lee Yeong Sing, Mohd Afiq Bin Mohd Amin, Sivanesan Ramasamy, Muhammad Firdaus Nasution Raduan, How Chi Keen. (2023). The foley catheter, an essential tool in the surgery for renal cell Carcinoma. 132(S2), 34
  8. Kuppusamy S, White P, Razack A, Gillatt D, Rhodes A, Doran O.Single Nucleotide Polymorphism (SNP) in CYP17A1 (rs743572) Gene as a Risk of Prostate Cancer Development A Preliminary Report in Caucasian Group (2011).
  9. Chee Loong Yeap, K Shanggar, Norman Dublin, Azad H Razack.2010 Sextant vs volume based extended transrectal ultrasound guided prostate biopsy- an experience of University Malaya Medical Centre (UMMC). International J of Urol Vol. 17; Suppl 1; A204-A205.
  10. Shanggar, K; Quek, KF; Razack, AH; Dublin, N.2010 The usefulness of Prostate Specific Antigen Density in Prostate Cancer detection: A Malaysian perspective. International J of Urol Vol. 17; Suppl 1; A203.
  11. S Kuppusamy, Faizal N, Quek, KF; Razack, AH; Dublin, N. The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound (TRUS) biopsy of prostate: a prospective randomized trial.2009 BJUI Vol. 103; Suppl 4, Pg 13.
  12. S Kuppusamy, K F Quek, A H Razack, N Dublin. Assessment of Diagnostic performance of Prostate Specific Antigen (PSA) in a nation of low Prostate cancer incidence.BJUI 2009 Vol. 103; Suppl 1, Pg 22.
  13. Shanggar K, Pavai S, Jayalakshmi P, Razack AH, Dublin N. 2008. The Use of Various Prostate Specific Antigen (PSA) Forms for Estimation of Prostate Cancer Risk. Indian Journal of Urology; Vol. 24, Suppl. 2, S131.
Other Publications
  1. NA - Mass Media(Newspaper,Radio,Tv,Popular Magazine)

RESEARCH PROJECT

National
  1. 2020 - 2024, Fundamental Research Grant Scheme (FRGS)
    Construing The Roles Of Adipokines And Their Mechanism In Renal Cell Carcinoma (rcc) ( Co-Researcher)
  2. 2020 - 2023, RU Geran - Fakulti Program
    Clinical And Molecular Investigation On The Role Of Cholesterol In Improving Drug Response In Bladder Cancer ( Co-Researcher)
  3. 2020 - 2023, Fundamental Research Grant Scheme (FRGS)
    Investigating The Mechanisms Behind Male Infertility In Hypothyroidism With Obesity: The Role Of Thyroid And Leptin Hormones ( Co-Researcher)
  4. 2019 - 2022, Others MOHE - Top 100 (IIRG)-HWB
    Characterization Of Farnesyl Diphosphate Farnesyltransferase 1 (fdft1) Expression In Cisplatin -treated Muscle -invasive Bladder Cancer ( Co-Researcher)
  5. 2017 - 2020, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
    Molecular profiling and pathway analysis of clinically aggressive Renal Cell Carcinoma ( Co-Researcher)
  6. 2017 - 2019, Fundamental Research Grant Scheme (FRGS)
    Establishing the role of histone H3 lysine 27(H3K27) demethylases in renal cell carcinoma and bladder cancers invasiveness and progression ( Principal Investigator(PI))
  7. 2021 - 2026, Merck Sharp & Dohme (M) Sdn. Bhd.
    A Phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-B15 / EV-304) ( Co-Researcher)
  8. 2019 - 2021, MKS Medic Sdn Bhd
    Comparing the DIfference in Detrusor Pressures at Maximal Flow Rate Between Air-Charged vs Water-Charged Catheters ( Consultant)
  9. 2019 - 2021, Private Funding
    Linguistic Translation and Validation of EORTC QLQ PR25 Questionnaire in Malay and Malaysian Chinese Language ( Supervisor)
  10. 2017 - 2020, Malaysian National Insitute of Health (NIH) Grant
    Asia Study Group of Prostate Cancer Malaysian Cohort (M-CaP Study) ( Consultant)
  11. 2016 - 2020, Private Funding
    A multicenter, prospective, longitudinal registry of patients with Prostate Cancer in Asia ( Consultant)
  12. 2017 - 2020, Private Funding
    A Phase IV Interventional Safety, Efficacy and Quality of Life Study of ELIGARD in Prostate Cancer Patients in Asia (ELIGANT) ( Consultant)
  13. 2016 - 2020, Private Funding
    A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE BLIND, PARALLEL GROUP, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONE OR MORE INTRADETRUSOR TREATMENTS OF 600 OR 800 UNITS OF DYSPORT FOR THE TREATMENT OF URINARY INCONTINENCE IN SUBJECTS WITH NEUROGENIC DETRUSOR OVERACTIVITY DUE TO SPINAL CORD INJURY OR MULTIPLE SCLEROSIS ( Consultant)
  14. 2017 - 2019, Fundamental Research Grant Scheme (FRGS)
    The expression of H3K27 demethylases from samples of renal cell carcinoma and bladder cancer patients. ( Principal Investigator(PI))
  15. 2016 - 2018, Yayasan Jiwa Malaysia
    Low Intensity Shock Wave Therapy for Erectile Dysfunction ( Principal Investigator(PI))
  16. 2010 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Study of polymorphisms of CYP3A and SRD5A2 genes and their association with risk of prostate cancer among multiethnic Malaysian men ( Principal Investigator(PI))
  17. 2010 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    Screening of genetic markers in Prostate Cancer in The Malaysian Population ( Consultant)
  18. 2008 - 2009, Short Term Research Fund (Vote F)(PJP)
    Prostate Specific Antigen (PSA) and its isoforms in the evaluation of Prostate Cancer ( Principal Investigator(PI))
International
  1. 2019 - 2024, Merck Sharp & Dohme (M) Sdn. Bhd
    KEYNOTE-676 : Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676) ( Consultant)
  2. 2020 - 2024, Johnson & Johnson
    PREVALENCE : A biomarker study to determine frequency of DNA-repair defects in men with metastatic prostate cancer. ( Consultant)
  3. 2015 - 2020, International Funding
    A multi-centre, prospective, longitudinal registry of patients with prostate cancer in Asia ( Consultant)
  4. 2018 - 2018, International Funding
    Robotic-a ssisted percutaneous access Interventional, non-randomized, open-label, non-comparative and First-in-Man Study ( Consultant)

CONSULTANCY PROJECT

  • Postgraduate Clinical Master Supervisors' Training 2021, Department of Surgery, Trainer
    27 Mar 2021 - 27 Oct 2021 (National)
  • Clinical Evaluation of Intermitent Catheter, Epsilon Medical Devices SDN.BHD, Consultant
    01 Jan 2021 - 31 Jul 2021 (National)
  • Malaysian Board of Urology (Mbu) Viva Preparatory Course, MALAYSIAN UROLOGICAL ASSOCIATION, Trainer
    10 Jul 2021 - 10 Jul 2021 (National)
  • Advanced Urology Course, Malaysian Board of Urology, Trainer
    26 Jun 2021 - 26 Jun 2021 (National)
  • Train The Trainee - Malaysian Board of Urology, Malaysian Board of Urology, Lead Trainer
    28 Mar 2021 - 28 Mar 2021 (National)
  • Train The Trainer - Malaysian Board of Urology, Malaysian Board of Urology, Lead Trainer
    30 Jan 2021 - 30 Jan 2021 (National)
  • Visiting Consultant for Renal Transplant Programme, Universiti Teknologi Mara
    01 Feb 2017 (National)

PAPER PRESENTED

INVITED SPEAKER
  1. Vesico and Ureterovaginal Fistulae, MALAYSIAN ENTEROSTOMAL THERAPY NURSING EDUCATION PROGRAM 2021, M&T Network Consultancy Services Sdn. Bhd. (National) (10 Sep 2021 - 10 Sep 2021)
  2. An Asian perspective E-based learning an assessment in urology: A new normal, UAA 2021, Urological Association of Asia (International) (19 Aug 2021 - 21 Aug 2021)
  3. UROCADEMY: An e-assessment module for urological training, EAU 2021, The European Association of Urology (International) (08 Jul 2021 - 12 Jul 2021)
  4. VVF, MALAYSIAN ENTEROSTOMAL THERAPY NURSING EDUCATION PROGRAM 2020, M&T Network Consultancy Services Sdn Bhd and UMMC (National) (03 Feb 2020 - 03 Feb 2020)
  5. PhAME 2019 , PhAME 2019 , Pfizer Malaysia (National) (14 Jul 2019 - 14 Jul 2019)
  6. To explore the possibility to formulate evidence based practical recommendations for the management of mestastatic prostate cancer, SOUTH EAST ASIA PROSTATE CANCER EXPERT MEET, South east asia prostate cancer (International) (25 Jun 2019 - 25 Jun 2019)
  7. A TEACHER'S TOOLKIT WORKSHOP: FOUNDATIONS OF ASSESSMENTS FOR HEALTH PROFESSIONALS, A TEACHER'S TOOLKIT WORKSHOP: FOUNDATIONS OF ASSESSMENTS FOR HEALTH PROFESSIONALS, MEDICAL EDUCATION AND RESEARCH DEVELOPMENT UNIT (MERDU) (University) (19 Jun 2019 - 19 Jun 2019)
  8. Prostate Cancer and Its Related Issues, Rotary Club Meeting , Rotary Club of Bangsar (National) (18 Apr 2017 - 18 Apr 2017)
  9. Management of Erectile Dysfunction in Diabetes, Malaysian Diabetes Educators Society Scientific Conference , Malaysian Diabetes Educators Society (National) (07 Apr 2017 - 09 Apr 2017)
  10. VVF and UVF, Malaysian Enterostomal Therapy Nursing Education Programme, Department of Nursing and Business Development Unit, PPUM (National) (22 Feb 2017 - 22 Feb 2017)
  11. Sexual Dysfunction, Men's Health Academy, Pfizer (National) (26 Mar 2016 - 27 Mar 2016)
  12. Vesico and Uretero Vaginal Fistulae, Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP), Enterostomal Therapist Team, UMMC and supported by Malaysian Ostomy Association (MOsA) (International) (14 Mar 2016 - 14 Mar 2016)
ORAL PRESENTER
  1. Ureterorenoscopy for Ureteric Calculi in Day Surgery An Analysis of 4 years Experience in UMMC, 16th Malaysian Urological Conference, Malaysian Urological Association (National) (07 Dec 2007 - 09 Dec 2007)
  2. Construction of Malay Version Of The Overactive Bladder Screener For Assessing Urinary Tract Symptoms in a Malaysian Population, 40th Malaysia-Singapore Congress of Medicine, Academy of Medicine of Malaysia (International) (25 Aug 2006 - 27 Aug 2006)
POSTER PRESENTER
  1. Restoring Sexual Function in Female with Pelvic Floor Tumour: A Sigmoid Colon Neovaginoplasty, 16th Malaysian Urological Conference, Malaysian Urological Association (National) (07 Dec 2007 - 09 Dec 2007)
  2. Renal Secondary of Metastatic Uterine Cervix Carcinoma Presented As A Non-resolving Abscess, 16th Malaysian Urological Conference, Malaysian Urological Association (National) (07 Dec 2007 - 09 Dec 2007)
  3. Extramammary Paget s disease: A Rare Series of 4 Peno-scrotal Neoplasm, 16th Malaysian Urological Conference, Malaysian Urological Association (National) (07 Dec 2007 - 09 Dec 2007)
PRESENTER
  1. Sextant vs volume based extended transrectal ultrasound guided prostate biopsy- an experience of University Malaya Medical Centre (UMMC)., Asian Congress of Urology (01 Oct 2010)
  2. The usefulness of Prostate Specific Antigen Density in Prostate Cancer detection: A Malaysian perspective., Asian Congress of Urology (27 Aug 2010)
  3. The efficacy of periprostatic local anaesthetic infiltration in transrectal ultrasound (TRUS) biopsy of prostate: a prospective randomized trial., British Association of Urological Surgeons 2009 Annual Scientific Meeting (International) (26 Jun 2009)
  4. Three Dimensional Volume rendering of Computerized Tomography for the Detection of Radioluscent Small Calculi Adjacent to The Ureteric , 16th Malaysian Urological Conference, Malaysian Urological Conference (National) (07 Dec 2007 - 09 Dec 2007)
  5. The Use of Various Prostate Specific Antigen (PSA) Forms for Estimation of Prostate Cancer Risk., 16th Malaysian Urological Conference, Malaysian Urological Association (National) (07 Dec 2007 - 09 Dec 2007)
  6. Extracorporeal Shock Wave Lithotripsy Therapy in The University of Malaya Medical Centre, 15th Malaysian Urology Congress, Malaysian Urological Association (National) (08 Dec 2006 - 10 Dec 2006)
OTHERS
  1. Organising Chairman, 27th Malaysian Urological Conference, Malaysian Urological Association (National) (22 Nov 2018 - 24 Nov 2018)
  2. Assessment of diagnostic performance of Prostate Specific Antigen (PSA) in a nation of low prostate cancer incidence, Urological Society of Australia and New Zealand Annual Scientifc Meeting, Urological Society of Australia and New Zealand (International) (08 Mar 2009 - 12 Mar 2009)
  3. The Use of Various Prostate Specific Antigen (PSA) Forms for Estimation of Prostate Cancer Risk, 9th Asian Congress of Urology, Asian Congress of Urology (International) (02 Oct 2008 - 05 Oct 2008)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2024) Editorial Board Member, International, (Reviewer)
  2. (2023) Wjso Reviewer, International, (Reviewer)
  3. (2023) Mahsa External Examiner and Assessor, National, (External Examiner)
  4. (2023) Mmc Accreditation Panel, National, (External Assessor)
  5. (2022) Urology Board Assessment, National, (Internal Assessor)
  6. (2022) Impact of Time-to-Surgery On The Prognosis of Patients With Pathological T1 Renal Cell Carcinoma After Nephrectomy, International, (Reviewer)
  7. (2022) Reviewer, International, (Reviewer)
  8. (2022) Board Evaluation and Urological Training Governance, National, (Internal Examiner)
  9. (2021) Prostate Biopsy in Young Patients With Hematospermia Without An Indication for Biopsy Contributed to The Early Diagnosis of Prostate Sarcoma: a Case Report, International, (Reviewer)
  10. (2021) Internal Examiner for Phd Thesis, University, (Internal Examiner)
  11. (2021) Omental Procedures During Peritoneal Dialysis Insertion: a Systematic Review and Meta Analysis, International, (Reviewer)
  12. (2021) Internal Examiner Stage 3.3 (Barrier), University, (Internal Examiner)
  13. (2021) The Prognosis and Clinicopathological Features of Different Distant Metastases Pattern in Renal Cell Carcinoma: Analysis Based On Seer Database, International, (Reviewer)
  14. (2021) Prognostic Value of Copine 1 in Patients With Renal Cell Carcinoma, International, (Reviewer)
  15. (2021) Competing Risk Analysis and Survival Prediction Model Construction of Metastatic Renal Cell Carcinoma : a Retrospective Cohort Study, International, (Reviewer)
  16. (2021) Internal Examiner for MBBS- Stage 1, University, (Internal Examiner)
  17. (2021) MBBS Osce Stage 2 Examiner, University, (Internal Examiner)
  18. (2021) Internal Examiner Master of Clinical Oncology, University, (Internal Examiner)
  19. (2020) Preliminary Study On The Relationship Between Chronic Inflammation and Biopsy Results in Prostate Biopsy, International, (Reviewer)
  20. (2019) UAA Congress 2019, (Reviewer)
  21. (2019) Facilitator/Speaker for the Oncological update, (Facilitator)
  22. (2019) Malaysian Journal of Medicine - Transperitoneal Laparoscopic Nephrectomy for Renal Tumour Disease versus Non-Tumour Disease: What are the Differences in Outcomes? , (Reviewer)
  23. (2019) Malaysian Journal of Medicine - EXTRAGASTROINTESTINAL STROMAL TUMOUR (EGIST) OF PROSTATE", (Reviewer)
  24. (2018) Malaysian Journal of Medicine , (Reviewer)
  25. (2018) MBBS Examination, (Internal Examiner)
  26. (2018) 8th Urology Update & 1st Workshop for Medical Officer, (Expert Speaker)
  27. (2018) Olympus Dinner Symposium, (Chairperson)
  28. (2018) Formulate scientific programme for UAA 2019 in Kuala Lumpur , (Scientific Committee)
  29. (2018) Advanced Nursing Education Programme, (Invited Speaker)
  30. (2018) MBU Viva Preparatory course, (External Examiner)
  31. (2016) Malaysia Urology Board Examiner, (External Examiner)
  32. (2016) Expert talk on kidney stones, (Expert advisor/ Resource person)
  33. (2016) Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP) organized by the Enterostomal Therapist (E.T) Team, University Malaya Medical Center 29 February 2016 27 May 2016, (Speaker)
  34. (2016) Educational Development for Urologists, (Speaker - Men's Health Academy)
  35. (2015) Master Medical Science to PhD Conversion Seminar for Ms Yap Ning Yi (MGN130058)., (Internal Examiner)
Contribution to external organisation
  1. (2024) Member of Siu Committee of National Society Delegates, International, (Resource Person)
  2. (2024) Board of Management Member, University, (Technical Advisor)
  3. (2024) Chairman of Umsc Medical and Dental Advisory Committee, University, (Technical Advisor)
  4. (2024) Advisor for Drug Control Authority, National, (Technical Advisor)
  5. (2024) Malaysian Representative to Siu Research Activity, International, (Expert Advisor)
  6. (2024) Chairman of Fees Committee, University, (Technical Advisor)
  7. (2024) Subcommittee for Education, National, (Technical Advisor)
  8. (2024) Member of Medical Advisory Committee (Mac), University, (Resource Person)
  9. (2023) Member of National Transplant Advisory Council, National, (Technical Advisor)
  10. (2022) National Urology Training Curriculum Writing, National, (Resource Person)
  11. (2021) Exam Question Writting Committee - Mbu, National, (Expert Advisor)
  12. (2021) Appointment as Curriculum Writing Committee Member for Parallel Entry Urology Programme, National, (Resource Person)
  13. (2019) Visiting Consultant Urologist (For Robotic Surgery) At Sunway Medical Centre, Sunway Medical Centre
  14. (2019) Trainer for Advanced Urology Course, Malaysian Urological Association
Contribution to event
  1. (2023) Faculty for Postgraduate Surgical Examiners' Training Workshop 2023, National, (Course Facilitator)
  2. (2023) Postgraduate Surgical Examiners' Training Workshop 2023- Organising Committee, National, (Event Organiser)
  3. (2023) Chairman and Moderator of Ipsen 3i Vision Symposium, International, (Panelist/Moderator)
  4. (2023) Menunited Symposium- Moderator, National, (Panelist/Moderator)
  5. (2023) Speaker in Recap 2023, National, (Course Facilitator)
  6. (2023) Organizing Committee of Recap 2023, National, (Event Organiser)
  7. (2022) Moderator of Bph Treatment, International, (Panelist/Moderator)
  8. (2022) Moderator in Poster Presentation, International, (Panelist/Moderator)
  9. (2022) Invited Speaker and Organiser, National, (Course Facilitator)
Media appearance
  1. (2023) Prostate Cancer Interview, National, (Interview)
  2. (2023) First Renal Transplant in Hiv Positive Patient, National, (Interview)
  3. (2023) First Renal Transplant in Hiv Positive Patient, National, (Interview)
  4. (2023) Father's Day Prostate Cancer Awareness, National, (Panelist/Moderator)
  5. (2023) First Renal Transplant in Hiv Positive Patient, National, (Interview)
  6. (2023) Prostae Cancer Awareness On Tv3, National, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2024) Adipokines as potential prognostic biomarkers and therapeutic target in renal cell carcinoma (RCC), SUGANIA MALAR CHINAPAYAN
  2. (2018) Expression of the oncogene ERG (V-ETS Erythroblastosis Virus E26 Oncogene Homolog) and activation of the androgen receptor in prostate cancer, Tan Jia Shin Jessica
  3. (2016) SINGLE NUCLEOTIDE POLYMORPHISMS, COPY NUMBER VARIATION AND PROTEIN PROFILES IN PROSTATE CANCER, PREVATHE A/P PONIAH
  4. (2016) Genomics and Proteomics of prostate cancer in Malaysian men, Prevathe a/p Poniah
  5. (2016) SINGLE NUCLEOTIDE POLYMORPHISMS, COPY NUMBER VARIATION AND PROTEIN PROFILES IN PROSTATE CANCER, PREVATHE A/P PONIAH
Master
  1. (2021) ASSESSMENT OF H3 LYSINE 27 (H3K27) DEMETHYLASES PROTEIN EXPRESSION AS POTENTIAL BIOMARKERS OF BLADDER CANCER, REBECCA ANTHONY
  2. (2020) THE EXPRESSION AND PROGNOSTIC VALUE OF H3 LYSINE 27 (H3K27) DEMETHYLASES IN BOTH RENAL CELL CARCINOMA AND BLADDER CANCERS, REBECCA ANTHONY
  3. (2019) THE EXPRESSION AND PROGNOSTIC VALUE OF H3 LYSINE 27 (H3K27) DEMETHYLASES IN BOTH RENAL CELL CARCINOMA AND BLADDER CANCERS, REBECCA ANTHONY
  4. (2019) Linguistic Translation and Validation of EORTC QLQ PR25 Questionnaire in Malay and Malaysian Chinese Language, Lim Wei Honn
  5. (2017) The Expression and Significance of H3 Lysine 27 (H3k27) Demethylases in both Renal Cell Carcinoma and Bladder Cancers : Patients Sample., Rebecca Anthony A/L Anthony Dass
  6. (2016) Adequacy of current analgesic protocol for Extracorporeal Shockwave Lithotripsy in UMMC, Dr. Vethunan a/l Tamalvanan
  7. (2015) Effect of ADT on Prostate cancer patients, Dr. Low Jer Wei
  8. (2014) Treatment of ED using LISWT, Dr. Dinesh Francis
  9. (2008) Prevalence of Hypogonadism and Metabolic Syndrome in Non-Urological patients, Dr. Koong Jun Kit
  10. (2006) Assessment of Nocturnal Penile Tumescence in Erectile Dysfunction Patients, Dr. Tee Chee Sian
Under Graduate Students
  1. (2022) To evaluate the relationship between erectile dysfunction (ED), based on the five-item International Index of Erectile Function questionnaire (IIEF-5), serum testosterone, and presence of metabolic syndrome (MetS) or its components.
  2. (2022) Bladder cancer registry
  3. (2021) The Impact of Recurrent Waves of Covid-19on the Mental Health of Medical Students: A Cross-Sectional Study
  4. (2021) Recurrent waves of Covid-19 and its impact on Medical Students: an assessment of awareness and preparedness.

TEACHING

Master
  1. (2022) NA - Frcs Urology
  2. (2022) NA - Master of Surgery
  3. (2021) MTA27500 - Advanced Clinical Training
  4. (2021) MTA2781A - Research Report
Bachelor
  1. (2022) MIA - Bachelor of Medicine, Bachelor of Surgery
  2. (2021) MIA - Bachelor of Medicine, Bachelor of Surgery
  3. (2016) DXED3102 - Human Disease
  4. (2014) DXED3102 - Human Disease
  5. (2009) DXED3102 - Human Disease
  6. (2008) DXED3102 - Human Disease

PATENT/IPR

  • USE OF INDICES RELATING TO LEVELS OF SERUM AND URINARY FRAGMENT PEPTIDES OF INTER-ALPHA TRYPSIN INHIBITOR LIGHT AND HEAVY CHAIN H4 FOR DIAGNOSIS AND/OR DISCRIMINATION OF PROSTATE CANCER
    PATENT

SOCIAL RESPONSIBILITY ACTIVITIES

  • Speaker - Prostate Cancer Society Malaysia, (17 Oct 2021 - 17 Oct 2021) (National)
  • 2nd Blue Cap Run 2016- Organising Committee (Deputy Chairman), (06 Nov 2016 - 06 Nov 2016)
  • 2nd Blue Cap Relay Run 2016, (06 Nov 2016 - 06 Nov 2016)
  • Projek Tanggungjawab Korporat Di Perkampungan Orang Asli Pulau Indah - Westports, (16 Oct 2010 - 16 Oct 2010)
  • UM Community Health Awareness Campaign 2010, (06 Feb 2010 - 07 Feb 2010)
  • Prostate Awareness Campaign, (13 Oct 2007 - 14 Oct 2007)

COURSE ATTENDED

External Course
INTERNATIONAL
  1. UAA Virtual Congress 2021, Virtual (19 Aug 2021 - 21 Aug 2021)